Sandoz Group AG Company Description

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide.

The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology.

It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. The company was founded in 1886 and is headquartered in Basel, Switzerland.

Sandoz Group AG

Country	Switzerland
Founded	1886
Industry	Pharmaceutical Preparations
Employees	22,049
CEO	Richard Saynor

Contact Details

Address: Centralbahnstrasse 4 Basel, 4051 Switzerland
Phone	41 61 324 11 11
Website	sandoz.com

Stock Details

Ticker Symbol	SDZ
Exchange	Vienna Stock Exchange
Fiscal Year	January - December
Reporting Currency	USD
SIC Code	2834

Key Executives

Name	Position
Richard Saynor	Chief Executive Officer
Remco Steenbergen	Chief Financial Officer
Craig Marks	Head of Investor Relations